Integra LifeSciences Holdings Corporation Free Cash Flow 2008–2025
Integra LifeSciences Holdings Corporation reported $-31.05M of free cash flow for fiscal 2025. That was 224.4% lower than fiscal 2024. Compared with fiscal 2020, the change was -118.8%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $-31.05M | -224.4% |
| FY 2024 | $24.96M | -65.8% |
| FY 2023 | $73.09M | -67.1% |
| FY 2022 | $222.13M | -16.0% |
| FY 2021 | $264.40M | +60.3% |
| FY 2020 | $164.94M | +1.9% |
| FY 2019 | $161.90M | +32.8% |
| FY 2018 | $121.94M | +71.7% |
| FY 2017 | $71.04M | +2.8% |
| FY 2016 | $69.08M | -3.3% |
| FY 2015 | $71.44M | +58.0% |
| FY 2014 | $45.23M | +312.4% |
| FY 2013 | $10.97M | +210.4% |
| FY 2012 | $-9.93M | -115.1% |
| FY 2011 | $65.90M | -3.7% |
| FY 2010 | $68.43M | -42.0% |
| FY 2009 | $118.00M | +99.4% |
| FY 2008 | $59.19M | — |
Source: Integra LifeSciences Holdings Corporation SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open IART 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Integra LifeSciences Holdings Corporation reported $-31.05M of free cash flow for fiscal 2025. That was 224.4% lower than fiscal 2024. Compared with fiscal 2020, the change was -118.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Integra LifeSciences Holdings Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeIntegra LifeSciences Holdings Corporation — frequently asked questions
What is Integra LifeSciences Holdings Corporation's free cash flow?
Integra LifeSciences Holdings Corporation (IART) reported free cash flow of $-31.05M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Integra LifeSciences Holdings Corporation's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.